Friday, May 30, 2008

Lupin gets tentative approval for TopiramateTablets

Indian based Company Lupin Pharmaceuticals Ltd. gets a tentative FDA approval for epileptic drug Topiramate. Topiramate (Topamax) is being sold by Ortho Mcneil, a subsidiary of Johnson & Johnson, used for the treatment of seizures.

 

Lupin said product will be introduce in the market once its patent expires in Sep 2008.  

 

 

Tuesday, May 20, 2008

Degree of Innovation in India

India-based Suven Life Sciences has got two granted product patents, one each in South Africa and China, for its new chemical treatments for disorders associated with neuro-degenerative diseases. The South African patent is valid until 2024 and the other until 2025.

Wednesday, May 14, 2008

Merck has received Patents in India for Obesity and Dyslipidemia Drugs

US-based Merck has received patent approval for two of its upcoming drugs for  dyslipidemia and obesity from the Indian Patent Office. The two newly patented drugs that are in the final stages of trial and are yet to receive the Drug Controller General of India’s (DCGI) approval.

 

Till now, Merck has only patent for its anti-diabetic drug called Januvia a 770 million product.

 

MSD Pharma is a wholly owned subsidiary of Merck & Co in India. Its director (marketing) Sanjiv Navangul said, “We have received patent approval for two more drugs in India which are in advanced Phase III trials. We soon expect to launch them here. However, we will have a competitive and right pricing for all our patented drugs based on comprehensive research.”